Studies have shown that Vcam1 levels are elevated in serum, urine and kidneys of SLE patients (Santos et al., 2012; Davies et al., 2021) and patients with active lupus nephritis (Svenungsson et al., 2008). Here, VCAM1 is linked to systemic lupus erythematosus.